TA
CVS icon

TruWealth Advisors’s CVS Health CVS Stock Holding History

TruWealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,454
Closed -$446K – 149
2023
Q2 		$446K Sell
6,454
-1,983
-24% -$141K 0.04% 93
2023
Q1 		$627K Buy
8,437
+551
+7% +$46.2K 0.06% 84
2022
Q4 		$735K Buy
7,886
+910
+13% +$87.8K 0.07% 81
2022
Q3 		$665K Buy
6,976
+1,805
+35% +$179K 0.07% 77
2022
Q2 		$479K Buy
5,171
+691
+15% +$67.4K 0.05% 80
2022
Q1 		$453K Buy
4,480
+143
+3% +$15K 0.05% 76
2021
Q4 		$447K Sell
4,337
-126
-3% -$11.6K 0.05% 79
2021
Q3 		$379K Sell
4,463
-14,465
-76% -$1.21M 0.04% 84
2021
Q2 		$1.58M Buy
18,928
+1,064
+6% +$87.1K 0.19% 52
2021
Q1 		$1.34M Buy
17,864
+574
+3% +$41.8K 0.18% 50
2020
Q4 		$1.18M Buy
+17,290
New +$1.12M 0.18% 51

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

TruWealth Advisors's CVS Position: Q3 2023 in Review

TruWealth Advisors sold out of CVS Health (CVS) in Q3 2023, closing a stake of 6,454 shares — an estimated $446K sold.

TruWealth Advisors first reported a position in CVS in Q4 2020 and held it in 11 quarters. The position peaked at $1.58M in Q2 2021. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • TruWealth Advisors reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • TruWealth Advisors sold 6,454 CVS Health shares in Q3 2023, an estimated $446K.
  • TruWealth Advisors first reported a position in CVS Health in Q4 2020 and held it in 11 quarters.
  • TruWealth Advisors's CVS Health position peaked at $1.58M in Q2 2021.
  • 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on TruWealth Advisors's 13F filing for Q3 2023, filed 10 Oct 2023.